Global Wearable Continuous Glucose Monitoring Devices Market - 2025-2033
Global Wearable Continuous Glucose Monitoring Devices Market Overview
The global wearable continuous glucose monitoring devices market reached US$ 12.20 billion in 2024 and is expected to reach US$ 32.48 billion by 2033, growing at a CAGR of 10.3% during the forecast period 2025-2033.
The wearable continuous glucose monitoring devices market is experiencing lucrative growth due to the rising prevalence of diabetes, increasing awareness among the diabetes population on disease management, and rising innovations from key market players. However, the affordability issues in the low and middle-income countries, accuracy, and calibration issues can hinder the adoption of CGMs at the anticipated rate.
Global Wearable Continuous Glucose Monitoring Devices Market Dynamics: Drivers & Restraints
The growing prevalence of diabetes is driving the market growth
Wearable glucose monitoring devices are gaining huge popularity due to their ability to track the patient's glucose levels continuously, and enable the physician/patient to make timely decisions. With the rising prevalence of diabetes and increasing awareness of disease management, the demand for continuous glucose monitoring devices is on the rise.
Prevalence of Diabetes, 2024 statistics; Source: International Diabetes Federation; NAC- North America & Caribbean, SCA- South & Central America, MENA- Middle East and North Africa
For instance, according to the International Diabetes Federation, in 2024, globally, 588.71 million people are living with diabetes, and by 2050, this number is expected to reach 852.47 million. Among these people, the adoption of wearable continuous glucose monitoring devices is rapidly growing. The presence of key market players such as Abbott, Dexcom, Inc., who have gained popularity in the diabetes devices landscape, and their constant innovations to fulfill the high unmet needs, is expected to further boost the market growth.
Accuracy and calibration issues may restrain the market growth
The continuous glucose monitoring systems are gaining huge popularity these days, however, they often have accuracy and calibration issues. These devices can sometimes produce deviated results from the actual blood glucose levels. As CGMs primarily rely on interstitial fluid glucose measurement, which can lag behind blood glucose changes by several minutes. As a result, users may experience discrepancies during rapid glucose fluctuations, such as after meals or exercise. Moreover, faulty sensors or transmitter components can hinder the device readings. These devices have to be calibrated on a timely basis to ensure their proper functioning. This can be a cumbersome activity for users and may lead to decreased adoption.
Global Wearable Continuous Glucose Monitoring Devices Market Segment Analysis
The global wearable continuous glucose monitoring devices market is segmented based on component, indication, age group, and region.
Sensors in the component segment accounted for 71.4% of the market share in 2024 in the global wearable continuous glucose monitoring devices market
The sensors component plays a crucial role in wearable continuous glucose monitoring (CGM) devices, as they provide real-time, accurate glucose measurements. Sensors are the core technology behind CGMs, as they continuously monitor blood glucose levels in interstitial fluid, offering users detailed and up-to-date information. With the increasing demand for more precise, real-time monitoring, advancements in sensor technology have enabled the development of more accurate, smaller, and longer-lasting devices.
Patients who are using continuous glucose monitoring devices must buy sensors regularly, as they are intended to be used for once. Several sensors from different manufacturers have varying lifespans, which can range from days to weeks. For instance, Abbott FreeStyle Libre 2, Abbott FreeStyle Libre 14-day, Abbott FreeStyle Libre 3 sensors have a lifespan of 14 days, Abbott FreeStyle Libre 2 Plus, Abbott FreeStyle Libre 3 Plus sensors have a lifespan of 15 days, Dexcom G6, Dexcom G7 sensors have a lifespan of 10 days, Medtronic Guardian Connect sensors have a lifespan of 7 days, whereas Eversense 365 CGM System sensors have a lifespan of 365 days. Once the sensors are utilized for a designated period, they must be replaced with new ones. Hence, a major portion of the overall spending of consumers on a CGM system goes to sensors. Moreover, key manufacturers in the market generate a major portion of their revenue from the sale of sensors.
Moreover, innovations in sensor design, such as improved accuracy, reduced size, and extended wear times, are driving the segment's growth. For instance, in August 2024, Dexcom launched Stelo, a new biosensor for adults with prediabetes and type 2 diabetes who do not use insulin. This is the first glucose measuring biosensor to be available in the United States over the counter. As people with diabetes seek more efficient and convenient ways to manage their condition, the demand for CGM systems with advanced sensors is growing. This makes the sensors segment a key driver in the wearable CGM market, as it directly impacts the overall performance and reliability of these devices.
Global Wearable Continuous Glucose Monitoring Devices Market Geographical Analysis
North America dominated the wearable continuous glucose monitoring devices market with the highest share of 53.4% in 2024
The North America region dominates the wearable continuous glucose monitoring devices due to various factors such as higher prevalence of diabetes, strong availability of advanced CGM systems, high purchasing power of consumers, favourable reimbursement policies, and constant innovations and product launches from market players.
For instance, according to International Diabetes Federation statistics, nearly 38 million people in the United States were living with diabetes in 2024, and by 2050, the diabetes population is expected to reach 42 million. This rising prevalence of diabetes drives the demand for advanced monitoring devices like continuous monitoring systems.
Additionally, market players are constantly innovating the advanced wearable CGMs that are gaining approvals from the Food and Drug Administration (FDA). For instance, in April 2025, the U.S. FDA approved DexCom, Inc.’s G7 15-Day continuous glucose monitoring system, designated for use in people over the age of 18 with diabetes in the United States. In March and June 2024, Dexcom and Abbott received clearance from the Food and Drug Administration (FDA) for their over-the-counter (OTC) continuous glucose monitors. Increasing approvals for products, such as over-the-counter continuous glucose monitors, are expected to drive the region’s market by expanding accessibility to glucose monitoring solutions. This will cater to a broader range of users, including those without insulin dependence. Thus, the above factors are expected to hold the region in the dominant position.
Global Wearable Continuous Glucose Monitoring Devices Market Competitive Landscape (Major Players)
The major players in the Wearable continuous glucose monitoring devices market are Dexcom, Inc., Abbott., Medtronic, Senseonics, F. Hoffmann-La Roche Ltd, and Afon Technology., among others.
Global Wearable Continuous Glucose Monitoring Devices Market Key Development
The global wearable continuous glucose monitoring devices market reached US$ 12.20 billion in 2024 and is expected to reach US$ 32.48 billion by 2033, growing at a CAGR of 10.3% during the forecast period 2025-2033.
The wearable continuous glucose monitoring devices market is experiencing lucrative growth due to the rising prevalence of diabetes, increasing awareness among the diabetes population on disease management, and rising innovations from key market players. However, the affordability issues in the low and middle-income countries, accuracy, and calibration issues can hinder the adoption of CGMs at the anticipated rate.
Global Wearable Continuous Glucose Monitoring Devices Market Dynamics: Drivers & Restraints
The growing prevalence of diabetes is driving the market growth
Wearable glucose monitoring devices are gaining huge popularity due to their ability to track the patient's glucose levels continuously, and enable the physician/patient to make timely decisions. With the rising prevalence of diabetes and increasing awareness of disease management, the demand for continuous glucose monitoring devices is on the rise.
Prevalence of Diabetes, 2024 statistics; Source: International Diabetes Federation; NAC- North America & Caribbean, SCA- South & Central America, MENA- Middle East and North Africa
For instance, according to the International Diabetes Federation, in 2024, globally, 588.71 million people are living with diabetes, and by 2050, this number is expected to reach 852.47 million. Among these people, the adoption of wearable continuous glucose monitoring devices is rapidly growing. The presence of key market players such as Abbott, Dexcom, Inc., who have gained popularity in the diabetes devices landscape, and their constant innovations to fulfill the high unmet needs, is expected to further boost the market growth.
Accuracy and calibration issues may restrain the market growth
The continuous glucose monitoring systems are gaining huge popularity these days, however, they often have accuracy and calibration issues. These devices can sometimes produce deviated results from the actual blood glucose levels. As CGMs primarily rely on interstitial fluid glucose measurement, which can lag behind blood glucose changes by several minutes. As a result, users may experience discrepancies during rapid glucose fluctuations, such as after meals or exercise. Moreover, faulty sensors or transmitter components can hinder the device readings. These devices have to be calibrated on a timely basis to ensure their proper functioning. This can be a cumbersome activity for users and may lead to decreased adoption.
Global Wearable Continuous Glucose Monitoring Devices Market Segment Analysis
The global wearable continuous glucose monitoring devices market is segmented based on component, indication, age group, and region.
Sensors in the component segment accounted for 71.4% of the market share in 2024 in the global wearable continuous glucose monitoring devices market
The sensors component plays a crucial role in wearable continuous glucose monitoring (CGM) devices, as they provide real-time, accurate glucose measurements. Sensors are the core technology behind CGMs, as they continuously monitor blood glucose levels in interstitial fluid, offering users detailed and up-to-date information. With the increasing demand for more precise, real-time monitoring, advancements in sensor technology have enabled the development of more accurate, smaller, and longer-lasting devices.
Patients who are using continuous glucose monitoring devices must buy sensors regularly, as they are intended to be used for once. Several sensors from different manufacturers have varying lifespans, which can range from days to weeks. For instance, Abbott FreeStyle Libre 2, Abbott FreeStyle Libre 14-day, Abbott FreeStyle Libre 3 sensors have a lifespan of 14 days, Abbott FreeStyle Libre 2 Plus, Abbott FreeStyle Libre 3 Plus sensors have a lifespan of 15 days, Dexcom G6, Dexcom G7 sensors have a lifespan of 10 days, Medtronic Guardian Connect sensors have a lifespan of 7 days, whereas Eversense 365 CGM System sensors have a lifespan of 365 days. Once the sensors are utilized for a designated period, they must be replaced with new ones. Hence, a major portion of the overall spending of consumers on a CGM system goes to sensors. Moreover, key manufacturers in the market generate a major portion of their revenue from the sale of sensors.
Moreover, innovations in sensor design, such as improved accuracy, reduced size, and extended wear times, are driving the segment's growth. For instance, in August 2024, Dexcom launched Stelo, a new biosensor for adults with prediabetes and type 2 diabetes who do not use insulin. This is the first glucose measuring biosensor to be available in the United States over the counter. As people with diabetes seek more efficient and convenient ways to manage their condition, the demand for CGM systems with advanced sensors is growing. This makes the sensors segment a key driver in the wearable CGM market, as it directly impacts the overall performance and reliability of these devices.
Global Wearable Continuous Glucose Monitoring Devices Market Geographical Analysis
North America dominated the wearable continuous glucose monitoring devices market with the highest share of 53.4% in 2024
The North America region dominates the wearable continuous glucose monitoring devices due to various factors such as higher prevalence of diabetes, strong availability of advanced CGM systems, high purchasing power of consumers, favourable reimbursement policies, and constant innovations and product launches from market players.
For instance, according to International Diabetes Federation statistics, nearly 38 million people in the United States were living with diabetes in 2024, and by 2050, the diabetes population is expected to reach 42 million. This rising prevalence of diabetes drives the demand for advanced monitoring devices like continuous monitoring systems.
Additionally, market players are constantly innovating the advanced wearable CGMs that are gaining approvals from the Food and Drug Administration (FDA). For instance, in April 2025, the U.S. FDA approved DexCom, Inc.’s G7 15-Day continuous glucose monitoring system, designated for use in people over the age of 18 with diabetes in the United States. In March and June 2024, Dexcom and Abbott received clearance from the Food and Drug Administration (FDA) for their over-the-counter (OTC) continuous glucose monitors. Increasing approvals for products, such as over-the-counter continuous glucose monitors, are expected to drive the region’s market by expanding accessibility to glucose monitoring solutions. This will cater to a broader range of users, including those without insulin dependence. Thus, the above factors are expected to hold the region in the dominant position.
Global Wearable Continuous Glucose Monitoring Devices Market Competitive Landscape (Major Players)
The major players in the Wearable continuous glucose monitoring devices market are Dexcom, Inc., Abbott., Medtronic, Senseonics, F. Hoffmann-La Roche Ltd, and Afon Technology., among others.
Global Wearable Continuous Glucose Monitoring Devices Market Key Development
- In September 2024, Senseonics Holdings, Inc., and Ascensia Diabetes Care announced that the U.S. Food and Drug Administration (FDA) approved the Eversense 365 CGM system. This is a next-generation 1-year continuous glucose monitoring device designed for patients aged 18 years or older with type 1 or type 2 diabetes.
- In September 2024, Abbott announced the availability of Lingo, a prescription-free continuous glucose monitoring device in the U.S. market. Lingo system is based on Abbott’s FreeStyle Libre continuous glucose monitoring technology and consists of a biosensor and a mobile app.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Component
2.4. Snippet by Indication
2.5. Snippet by Age Group
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Growing Prevalence of Diabetes
3.1.1.2. Technological Advancements in CGMs
3.1.2. Restraints
3.1.2.1. Accuracy and Calibration Issues
3.1.2.2. High Cost of Advanced Devices and Maintenance
3.1.3. Opportunities
3.1.3.1. Integration of CGMs with Insulin Pumps and Development of Closed Loop Systems
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. SWOT Analysis
4.7. Unmet Needs and Gaps
4.8. Recommended Strategies for Market Entry and Expansion
4.9. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.10. Key Opinion Leaders
5. GLOBAL WEARABLE CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY COMPONENT
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
5.1.2. Market Attractiveness Index, By Component
5.2. Receiver or Display Device*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Sensors
5.4. Transmitters
5.5. Others
6. GLOBAL WEARABLE CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY INDICATION
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
6.1.2. Market Attractiveness Index, By Indication
6.2. Type 1 Diabetes*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Type 2 Diabetes
7. GLOBAL WEARABLE CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY AGE GROUP
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
7.1.2. Market Attractiveness Index, By Age Group
7.2. Children*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Adults
7.4. Geriatrics
8. GLOBAL WEARABLE CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY REGION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Dexcom, Inc.*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.2. Abbott.
10.3. Medtronic
10.4. Senseonics
10.5. F. Hoffmann-La Roche Ltd
10.6. Afon Technology.
THE LIST IS NOT EXHAUSTIVE
11. APPENDIX
11.1. About Us and Services
11.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Component
2.4. Snippet by Indication
2.5. Snippet by Age Group
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Growing Prevalence of Diabetes
3.1.1.2. Technological Advancements in CGMs
3.1.2. Restraints
3.1.2.1. Accuracy and Calibration Issues
3.1.2.2. High Cost of Advanced Devices and Maintenance
3.1.3. Opportunities
3.1.3.1. Integration of CGMs with Insulin Pumps and Development of Closed Loop Systems
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. SWOT Analysis
4.7. Unmet Needs and Gaps
4.8. Recommended Strategies for Market Entry and Expansion
4.9. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.10. Key Opinion Leaders
5. GLOBAL WEARABLE CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY COMPONENT
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
5.1.2. Market Attractiveness Index, By Component
5.2. Receiver or Display Device*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Sensors
5.4. Transmitters
5.5. Others
6. GLOBAL WEARABLE CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY INDICATION
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
6.1.2. Market Attractiveness Index, By Indication
6.2. Type 1 Diabetes*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Type 2 Diabetes
7. GLOBAL WEARABLE CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY AGE GROUP
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
7.1.2. Market Attractiveness Index, By Age Group
7.2. Children*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Adults
7.4. Geriatrics
8. GLOBAL WEARABLE CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY REGION
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age-Group
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Dexcom, Inc.*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.2. Abbott.
10.3. Medtronic
10.4. Senseonics
10.5. F. Hoffmann-La Roche Ltd
10.6. Afon Technology.
THE LIST IS NOT EXHAUSTIVE
11. APPENDIX
11.1. About Us and Services
11.2. Contact Us
LIST OF TABLES
Table 1 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 7 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 9 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 11 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 14 North America Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 15 North America Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 16 North America Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 South America Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 18 South America Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 19 South America Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 20 South America Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 22 Europe Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 23 Europe Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 24 Europe Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Dexcom, Inc.: Overview
Table 34 Dexcom, Inc.: Product Portfolio
Table 35 Dexcom, Inc.: Key Developments
Table 36 Abbott.: Overview
Table 37 Abbott.: Product Portfolio
Table 38 Abbott.: Key Developments
Table 39 Medtronic: Overview
Table 40 Medtronic: Product Portfolio
Table 41 Medtronic: Key Developments
Table 42 Senseonics: Overview
Table 43 Senseonics: Product Portfolio
Table 44 Senseonics: Key Developments
Table 45 F. Hoffmann-La Roche Ltd: Overview
Table 46 F. Hoffmann-La Roche Ltd: Product Portfolio
Table 47 F. Hoffmann-La Roche Ltd: Key Developments
Table 48 Afon Technology.: Overview
Table 49 Afon Technology.: Product Portfolio
Table 50 Afon Technology.: Key Developments
Table 1 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 7 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 9 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 11 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Wearable Continuous Glucose Monitoring Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 14 North America Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 15 North America Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 16 North America Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 South America Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 18 South America Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 19 South America Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 20 South America Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 22 Europe Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 23 Europe Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 24 Europe Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, By Component, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, By Indication, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, By Age Group, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Dexcom, Inc.: Overview
Table 34 Dexcom, Inc.: Product Portfolio
Table 35 Dexcom, Inc.: Key Developments
Table 36 Abbott.: Overview
Table 37 Abbott.: Product Portfolio
Table 38 Abbott.: Key Developments
Table 39 Medtronic: Overview
Table 40 Medtronic: Product Portfolio
Table 41 Medtronic: Key Developments
Table 42 Senseonics: Overview
Table 43 Senseonics: Product Portfolio
Table 44 Senseonics: Key Developments
Table 45 F. Hoffmann-La Roche Ltd: Overview
Table 46 F. Hoffmann-La Roche Ltd: Product Portfolio
Table 47 F. Hoffmann-La Roche Ltd: Key Developments
Table 48 Afon Technology.: Overview
Table 49 Afon Technology.: Product Portfolio
Table 50 Afon Technology.: Key Developments
LIST OF FIGURES
Figure 1 Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 3 Global Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 4 Global Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 5 Global Wearable Continuous Glucose Monitoring Devices Market Share, By Region, 2025 & 2033 (%)
Figure 6 Global Wearable Continuous Glucose Monitoring Devices Market Y-o-Y Growth, By Component, 2025-2033 (%)
Figure 7 Receiver or Display Device Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Sensors Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Transmitters Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Others Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 Global Wearable Continuous Glucose Monitoring Devices Market Y-o-Y Growth, By Indication, 2025-2033 (%)
Figure 12 Type 1 Diabetes Indication in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 13 Type 2 Diabetes Indication in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Global Wearable Continuous Glucose Monitoring Devices Market Y-o-Y Growth, By Age Group, 2025-2033 (%)
Figure 15 Children Age Group in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Adults Age Group in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Geriatrics Age Group in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 18 Global Wearable Continuous Glucose Monitoring Devices Market Y-o-Y Growth, By Region, 2025-2033 (%)
Figure 19 North America Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 North America Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 21 North America Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 22 North America Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 23 North America Wearable Continuous Glucose Monitoring Devices Market Share, By Country, 2025 & 2033 (%)
Figure 24 South America Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 South America Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 26 South America Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 27 South America Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 28 South America Wearable Continuous Glucose Monitoring Devices Market Share, By Country, 2025 & 2033 (%)
Figure 29 Europe Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 30 Europe Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 31 Europe Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 32 Europe Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 33 Europe Wearable Continuous Glucose Monitoring Devices Market Share, By Country, 2025 & 2033 (%)
Figure 34 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 35 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 36 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 37 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 38 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Share, By Country, 2025 & 2033 (%)
Figure 39 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 40 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 41 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 42 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 43 Dexcom, Inc.: Financials
Figure 44 Abbott.: Financials
Figure 45 Medtronic: Financials
Figure 46 Senseonics: Financials
Figure 47 F. Hoffmann-La Roche Ltd: Financials
Figure 48 Afon Technology.: Financials
Figure 1 Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 3 Global Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 4 Global Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 5 Global Wearable Continuous Glucose Monitoring Devices Market Share, By Region, 2025 & 2033 (%)
Figure 6 Global Wearable Continuous Glucose Monitoring Devices Market Y-o-Y Growth, By Component, 2025-2033 (%)
Figure 7 Receiver or Display Device Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Sensors Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Transmitters Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Others Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 Global Wearable Continuous Glucose Monitoring Devices Market Y-o-Y Growth, By Indication, 2025-2033 (%)
Figure 12 Type 1 Diabetes Indication in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 13 Type 2 Diabetes Indication in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Global Wearable Continuous Glucose Monitoring Devices Market Y-o-Y Growth, By Age Group, 2025-2033 (%)
Figure 15 Children Age Group in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Adults Age Group in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Geriatrics Age Group in Global Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 18 Global Wearable Continuous Glucose Monitoring Devices Market Y-o-Y Growth, By Region, 2025-2033 (%)
Figure 19 North America Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 North America Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 21 North America Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 22 North America Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 23 North America Wearable Continuous Glucose Monitoring Devices Market Share, By Country, 2025 & 2033 (%)
Figure 24 South America Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 South America Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 26 South America Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 27 South America Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 28 South America Wearable Continuous Glucose Monitoring Devices Market Share, By Country, 2025 & 2033 (%)
Figure 29 Europe Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 30 Europe Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 31 Europe Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 32 Europe Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 33 Europe Wearable Continuous Glucose Monitoring Devices Market Share, By Country, 2025 & 2033 (%)
Figure 34 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 35 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 36 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 37 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 38 Asia-Pacific Wearable Continuous Glucose Monitoring Devices Market Share, By Country, 2025 & 2033 (%)
Figure 39 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Value, 2022-2033 (US$ Billion)
Figure 40 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Share, By Component, 2025 & 2033 (%)
Figure 41 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 & 2033 (%)
Figure 42 Middle East and Africa Wearable Continuous Glucose Monitoring Devices Market Share, By Age Group, 2025 & 2033 (%)
Figure 43 Dexcom, Inc.: Financials
Figure 44 Abbott.: Financials
Figure 45 Medtronic: Financials
Figure 46 Senseonics: Financials
Figure 47 F. Hoffmann-La Roche Ltd: Financials
Figure 48 Afon Technology.: Financials
